The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Category: News
Angle Abnormalities, Heterochromia Iridis May Play Role In Glaucoma Development In Sturge-Weber Syndrome
Anterior chamber angle abnormalities and heterochromic iridis may be linked to the development of glaucoma in infants with Sturge-Weber syndrome, according to a study.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Future Bleak For New Antibiotic Development
The field of medicine in general, and ophthalmology in particular, has seen a dramatic slowdown in the development of novel antibiotics, and the immediate future appears to offer no real promise.
Commercialization Of The Most Promising Research At BGU
A Los Angeles philanthropist has created an innovative foundation model that will provide up to $1.2 million to help fund and commercialize research at Ben-Gurion University of the Negev in Beer-Sheva, Israel…
More Than 72,000 Clinical Photographs Illustrate Age-Related Eye Disease Progression
The National Institutes of Health has expanded a genetic and clinical research database to give researchers access to the first digital study images…
Tallis PR: Ophthalmos Collects Platinum Award For Lens-Free Ophthalmoscope
New screening device wins at Nursing Times Product Awards Optyse™, the lens-free ophthalmoscope has been recognised with a Platinum Award in the Patient Observation category at the inaugural Nursing Times Product Awards…
Company Profile for Iris Pharma
–(BUSINESS WIRE)–Iris Pharma is an independent Contract Research Organization (CRO), dedicated to preclinical and clinical research in ophthalmology.
University Study Points To Method Of Reversing Age-Related Decline In Vision
Elderly adults can improve their vision with perceptual training, according to a study from the University of California, Riverside and Boston University that has implications for the health and mobility of senior citizens. The study, “Perceptual learn…
Scleral Spacing Procedures Showing Restoration Of Accommodation
While they have been slow to gain wide acceptance in the ophthalmology community, scleral spacing procedures have shown the ability to restore accommodation in presbyopic eyes, according to one presenter here.
Less-Frequent Injected Drug Works in Wet Macular Degeneration
Regeneron Pharmaceuticals Inc’s treatment for wet macular degeneration was as effective and safe in two late-stage trials as Roche Holding AG’s blockbuster Lucentis, with half the number of eye injections. Reuters Health Information
Research and Markets: Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. The report provides key data, information and analysis on the global premium IOLs market.
FDA Clearance Granted For The First Clinical Trial Using Embryonic Stem Cells To Treat Macular Degeneration
Advanced Cell Technology, Inc…
Mimetogen Pharmaceuticals Announces Initiation Of Phase II Clinical Trial Of Novel NGF Mimetic In Patients With Dry Eye
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3,…
USFDA grants Sun Pharma tentative marketing approval for generic Cymbalta
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Cymbalta®, duloxetine hydrochloride delayed-release capsules.
New Treatment Targets Natural Tears For Dry Eyes
Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease (“Dry Eye”). RESTASIS® is the first prescription eye drop to ta…
Surgeon Laments Limited Availability Of Cross-Linking In US
Although UV-riboflavin collagen cross-linking is currently undergoing clinical trials in the United States, one surgeon expressed dissatisfaction that the procedure still lacks U.S. Food and Drug Administration approval for treating corneal disorders s…
New Treatment Targets Natural Tears For Dry Eyes
Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease (“Dry Eye”). RESTASIS® is the first prescription eye drop to ta…